Clorox slides as CEO Linda Rendle plans to step down, adding uncertainty after a lowered FY2026 outlook

The Clorox Company (CLX) is down 6.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is a leadership shakeup after Clorox disclosed that Chair and CEO Linda Rendle plans to step down for health reasons and the board has initiated a comprehensive CEO search. The move also appears to be amplified by already-cautious sentiment following the company’s recent FY2026 outlook reduction and added leverage tied to the GOJO (Purell) acquisition.

Details:

Clorox announced on May 28, 2026 that CEO Linda Rendle asked the board to begin a CEO search process as she intends to step down for health reasons; she is expected to remain in place until a successor is appointed and then serve in an advisory role.

The announcement introduces near-term execution risk for a consumer staples company that has been managing margin pressure, demand softness in some categories, and operational initiatives (including ERP-related workstreams).

In its April 30, 2026 quarterly update, Clorox updated full-year fiscal 2026 guidance, reflecting a tougher operating backdrop and incorporating items tied to the GOJO acquisition.

Clorox also completed a multi-tranche senior notes offering in May 2026, which can draw investor focus to leverage and interest expense at a time when the company is working to stabilize earnings.

Sources:

PR Newswire, The Clorox Company (investor materials), SEC (EDGAR)

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CLX Insider Trading Activity

$CLX insiders have traded $CLX stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CLX stock by insiders over the last 6 months:

PIERRE R BREBER purchased 5,000 shares for an estimated $429,124

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive CLX Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$CLX Hedge Fund Activity

We have seen 549 institutional investors add shares of $CLX stock to their portfolio, and 571 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

STIFEL FINANCIAL CORP removed 2,378,720 shares (-78.3%) from their portfolio in Q4 2025, for an estimated $239,846,337
POINT72 ASSET MANAGEMENT, L.P. added 1,234,932 shares (+345.6%) to their portfolio in Q1 2026, for an estimated $124,672,560
TWO SIGMA INVESTMENTS, LP removed 929,055 shares (-88.2%) from their portfolio in Q1 2026, for an estimated $93,792,747
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 892,381 shares (-55.1%) from their portfolio in Q1 2026, for an estimated $90,090,323
INVESCO LTD. added 884,751 shares (+22.1%) to their portfolio in Q4 2025, for an estimated $89,209,443
FMR LLC added 822,022 shares (+127.0%) to their portfolio in Q1 2026, for an estimated $82,987,231
TWO SIGMA ADVISERS, LP removed 778,100 shares (-38.2%) from their portfolio in Q4 2025, for an estimated $78,455,823

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CLX Congressional Stock Trading

Members of Congress have traded $CLX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $CLX stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 12/19.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CLX Price Targets

Multiple analysts have issued price targets for $CLX recently. We have seen 11 analysts offer price targets for $CLX in the last 6 months, with a median target of $97.0.

Here are some recent targets:

Chris Carey from Wells Fargo set a target price of $95.0 on 05/18/2026
Lauren Lieberman from Barclays set a target price of $85.0 on 05/04/2026
Javier Escalante from Evercore ISI Group set a target price of $110.0 on 05/01/2026
Andrea Teixeira from JP Morgan set a target price of $95.0 on 05/01/2026
Filippo Falorni from Citigroup set a target price of $97.0 on 05/01/2026
Peter Grom from UBS set a target price of $96.0 on 05/01/2026
Dara Mohsenian from Morgan Stanley set a target price of $110.0 on 04/23/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.